Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 90 of the 96 references it cites were found in a registry or an index; 79 of the 207 sources its claims cite were checked for support.

Stakeholders' views on the use of psychotropic medication in older people: a systematic review

Open access

Abstract

Background: psychotropic medication use has been shown to increase with age and has been associated with increased risk of falls, strokes and mortality. Various guidelines, regulations and tools have been developed to reduce inappropriate prescribing, but this remains high. In order to understand the reasons for this, we aimed to systematically review healthcare professionals', patients' and family caregivers' attitudes towards the use of psychotropic medication in older people. Methods: a systematic literature search was carried out from inception to September 2020 using PUBMED, EMBASE, PsycINFO and CINAHL and hand-searching of reference lists. Included studies investigated stakeholder views on psychotropic in adults over the age of 65. Findings were thematically synthesised. Results: overall, there was an acceptance of long-term psychotropic medication for older people both living in the community and in residential care. While healthcare professionals were aware of guidelines for the use of benzodiazepines and psychotropic medicines, they identified barriers to following them on individual, team and organisational levels. Alternative non-pharmacological approaches were not always available or accepted by patients. Conclusion: psychotropic medicine use in older adults remains a complex issue, which needs to be addressed on a broad level. Attitudes of older people and healthcare professionals encourage long-term use. Meanwhile, various internal and external factors act as barriers to the use of non-drug alternatives in this population. In order to reduce overprescribing of psychotropics, there is a need to increase the acceptability and accessibility of alternative interventions in both care homes and the community. © 2022 The Author(s).

Overview

CoChat Summary

## TL;DR

This systematic review found broad acceptance of long-term psychotropic medication for older people among older adults, family caregivers, and healthcare professionals, alongside clear barriers to deprescribing and to using non-drug alternatives. The authors conclude that reducing overprescribing will require broader changes, including improving the acceptability and accessibility of alternative interventions in care homes and the community.

## Key findings

  • The review included 34 studies and 3,398 stakeholders: 2,712 healthcare and care home staff, 631 older people, and 55 family caregivers.
  • Across the included studies, there was acceptance of long-term psychotropic medication in both community and residential care settings.
  • Four themes were identified: acceptance of long-term psychotropic medication, risk benefit assessment, best practice versus actual practice, and organisational factors.
  • The review reports that psychotropic review interventions reduced prescribing rates by 28–82% in prior studies cited in the discussion.
  • Study quality scores ranged from 31% to 100%.

## Methods

  • Systematic review of qualitative and descriptive evidence, reported following PRISMA guidance.
  • Searched EMBASE, MEDLINE, CINAHL plus, and PsycINFO from inception to September 2020, plus reference lists; included studies on stakeholders’ views about psychotropic use in adults ≥65 years.
  • Studies were appraised with the QATSDD tool, and findings were synthesized using thematic synthesis; meta-analysis was not carried out because of heterogeneity in data and study designs.

## Limitations

  • The paper states that excluding non-English papers may have excluded useful studies; it also notes that all included studies were from North America, Australia, and Europe.
  • The authors say some included studies had “conceptually poor” or “thin” data, which may have limited the thematic synthesis.
  • The studies varied greatly in quality; this is stated in the paper, though the authors note themes were consistent across studies.
  • Evident from the text: the review did not include the public, only defined stakeholder groups, so broader societal views are not represented.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/ageing/afac060

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [41].
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [41].CC BY-NC · PubMed Central

Verification

Claims the paper makes

36 Valid · 6 Not valid · 30 Not checked · 48 Own results and interpretations

36 more claims · 10 with their cited sources checked

Create a free account to see all 120 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 61
  • It may state two separate claims as one. 37

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 96 references

Research works printed but not linked: 8

  1. National Institute for Health and Care Excellence (NICE), First-Choice Antidepressant Use in Adults with Depression or Generalised Anxiety Disorder Key Therapeutic Topic [KTT8]
  2. National Institute for Health and Care Excellence (NICE), Antipsychotics in People Living with Dementia [KTT7]
  3. National Institute for Health and Care Excellence (NICE), Dementia: Assessment, Management and Support for People Living with Dementia and Their Carers NICE Guidance [NG97]
  4. Royal College of Psychiatrists, National Audit of Dementia: Prescription of Psychotropic Medication Initiated in Hospital for Behavioural and Psychological Symptoms of Dementia
  5. Commissioning for Quality and Innovation (CQUIN), CCG7: Three High Impact Actions to Prevent Hospital Falls
  6. New South Wales Therapeutic Advisory Group, DeprescribingTools
  7. National Institute for Health and Care Excellence (NICE), Older People: Independence and Mental Wellbeing NICE Guideline [NG32]
  8. Noyes, Chapter 21: Qualitative Evidence

Cited by

See all 22

Metadata

Authors
Bednarczyk, E., Cook, S., Brauer, R., & Garfield, S.
Affiliations
  • UCL School of Pharmacy (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Imperial College Healthcare NHS Trust (GB)
Corresponding author
Bednarczyk, Eliza
Venue
Age and Ageing
Published
2022-03-01
Volume
51
Issue
3
ISSN
  • 0002-0729 (ISSN-L)
  • 1468-2834
OpenAlex
W4214868182
Cited by
22
References
96
Citations by year
2026: 3 · 2025: 6 · 2024: 9 · 2023: 2 · 2022: 2
FWCI
0.68
Type
journal article
Language
en
Open access
Locations
  • Age and Ageing (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
psychotropic drugs, older adults, inappropriate prescribing, benzodiazepines, stakeholder attitudes, healthcare workers, patients, family caregivers, non-pharmacological treatment, residential care, community-dwelling older adults, chronic drug administration
MeSH terms
Accidental Falls, Aged, Health Personnel, Humans, Psychotropic Drugs, Caregivers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.